|
🦁
|
Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.
39 auth.
J. Gunst,
N. B. Staerke,
M. H. Pahus,
L. Kristensen,
J. Bodilsen,
N. Lohse,
L. S. Dalgaard,
D. Brønnum,
Ole Fröbert,
B. Hønge,
I. Johansen,
Ida Monrad,
C. Erikstrup,
Regitze Rosendal,
Emil Vilstrup,
...
T. Mariager,
D. Bové,
Rasmus Offersen,
S. Shakar,
S. Cajander,
N. Jørgensen,
S. Sritharan,
P. Breining,
Søren E. Jespersen,
K. Mortensen,
M. Jensen,
L. Kolte,
Giacomo S. Frattari,
C. Larsen,
M. Storgaard,
L. P. Nielsen,
M. Tolstrup,
E. Sædder,
L. Østergaard,
H. Ngo,
M. H. Jensen,
J. F. Højen,
Mads Kjolby,
O. Søgaard
|
7 |
2021 |
7
🦁
|
|
🐜
|
SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses
17 auth.
Line K. Vibholm,
S. Nielsen,
M. H. Pahus,
Giacomo S. Frattari,
R. Olesen,
R. Andersen,
Ida Monrad,
A. Andersen,
Michelle M. Thomsen,
C. Konrad,
...
S. D. Andersen,
J. F. Højen,
J. Gunst,
L. Østergaard,
O. Søgaard,
M. Schleimann,
M. Tolstrup
|
6 |
2021 |
6
🐜
|
|
🐜
|
Camostat mesylate against SARS‐CoV‐2 and COVID‐19—Rationale, dosing and safety
11 auth.
P. Breining,
A. Frolund,
J. F. Højen,
J. Gunst,
N. B. Staerke,
E. Saedder,
...
M. Cases-Thomas,
Paul Little,
L. Nielsen,
O. Søgaard,
Mads Kjolby
|
6 |
2020 |
6
🐜
|
|
🦁
|
Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial
33 auth.
J. Gunst,
M. H. Pahus,
Míriam Rosás-Umbert,
I-Na Lu,
T. Benfield,
H. Nielsen,
I. Johansen,
R. Mohey,
Lars Østergaard,
Vibeke Klastrup,
Maryam Khan,
M. Schleimann,
R. Olesen,
H. Støvring,
P. W. Denton,
...
N. Kinloch,
D. Copertino,
A. Ward,
W. C. Alberto,
S. Nielsen,
M. Puertas,
Victor Ramos,
J. Reeves,
C. Petropoulos,
J. Martinez-Picado,
Z. Brumme,
R. B. Jones,
J. Fox,
M. Tolstrup,
M. Nussenzweig,
M. Caskey,
S. Fidler,
O. Søgaard
|
6 |
2022 |
6
🦁
|
|
🐜
|
TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS‐CoV‐2 infection
26 auth.
Renée M. Van der Sluis,
Lamin B. Cham,
Albert Gris‐Oliver,
K. R. Gammelgaard,
J. Pedersen,
M. Idorn,
U. Ahmadov,
Sabina Sanches Hernandez,
Ena Cémalovic,
S. H. Godsk,
Jacob Thyrsted,
J. Gunst,
S. Nielsen,
Janni J. Jørgensen,
T. Bjerg,
...
Anders Laustsen,
L. Reinert,
D. Olagnier,
R. Bak,
Mads Kjolby,
C. Holm,
M. Tolstrup,
S. Paludan,
L. Kristensen,
O. Søgaard,
M. Jakobsen
|
6 |
2022 |
6
🐜
|
|
🐜
|
Results of a Multinational Study Suggest the Need for Rapid Diagnosis and Early Antiviral Treatment at the Onset of Herpetic Meningoencephalitis
51 auth.
H. Erdem,
Y. Çağ,
D. Ozturk-Engin,
S. Defres,
S. Kaya,
L. Larsen,
M. Poljak,
B. Baršić,
X. Argemi,
S. M. Sørensen,
A. Bohr,
P. Tattevin,
J. Gunst,
L. Baštáková,
M. Jereb,
...
I. Johansen,
O. Karabay,
A. Pekok,
O. Sipahi,
M. Chehri,
G. Béraud,
G. Shehata,
Rosa Fontana del Vecchio,
M. Maresca,
H. Karsen,
G. Sengoz,
M. Sunbul,
G. Yılmaz,
Hava Yılmaz,
A. Sharif‐Yakan,
S. Kanj,
E. Parlak,
F. Pehlivanoğlu,
F. Korkmaz,
S. Komur,
S. Kose,
M. Ulug,
S. Bolukçu,
S. A. Coşkuner,
N. Ince,
Y. Akkoyunlu,
G. Halac,
E. Şahin-Horasan,
H. Tireli,
G. Kilicoglu,
A. Al-Mahdawi,
S. A. Nemli,
A. Inan,
S. Şenbayrak,
J. Stahl,
H. Vahaboğlu
|
6 |
2015 |
6
🐜
|
|
🐜
|
SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity
15 auth.
S. Nielsen,
Line K. Vibholm,
Ida Monrad,
R. Olesen,
Giacomo S. Frattari,
M. H. Pahus,
J. F. Højen,
J. Gunst,
C. Erikstrup,
Andreas Holleufer,
...
R. Hartmann,
L. Østergaard,
O. Søgaard,
M. Schleimann,
M. Tolstrup
|
5 |
2020 |
5
🐜
|
|
🐬
|
The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies
J. Martinsen,
J. Gunst,
J. F. Højen,
M. Tolstrup,
O. Søgaard
|
5 |
2020 |
5
🐬
|
|
🐜
|
Persistent Symptoms in Patients Recovering From COVID-19 in Denmark
9 auth.
S. Leth,
J. Gunst,
V. Mathiasen,
K. Hansen,
O. Søgaard,
L. Østergaard,
...
S. Jensen-Fangel,
M. Storgaard,
J. Agergaard
|
5 |
2021 |
5
🐜
|
